{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:06:48Z","timestamp":1790928408003,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC-112-2314-B-A49-072"],"award-info":[{"award-number":["NSC-112-2314-B-A49-072"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-010-061 -"],"award-info":[{"award-number":["109-2314-B-010-061 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2314-B-075-051-MY3"],"award-info":[{"award-number":["106-2314-B-075-051-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005799","name":"National Yang Ming Chiao Tung University","doi-asserted-by":"publisher","award":["E107F-M01-0501"],"award-info":[{"award-number":["E107F-M01-0501"]}],"id":[{"id":"10.13039\/501100005799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW104-TDU-B-211-113-003"],"award-info":[{"award-number":["MOHW104-TDU-B-211-113-003"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW106-TDU-B-211-113-001"],"award-info":[{"award-number":["MOHW106-TDU-B-211-113-001"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.thromres.2024.04.032","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T08:33:03Z","timestamp":1714552383000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis"],"prefix":"10.1016","volume":"238","author":[{"given":"Kun-Han","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Tyng","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Lun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Yu","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.04.032_bb0005","doi-asserted-by":"crossref","unstructured":"Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat. Rev. Cardiol. Nov 2014;11(11):639\u201354. doi:https:\/\/doi.org\/10.1038\/nrcardio.2014.118.","DOI":"10.1038\/nrcardio.2014.118"},{"key":"10.1016\/j.thromres.2024.04.032_bb0010","doi-asserted-by":"crossref","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. Feb 21 2023;147(8):e93-e621. doi:https:\/\/doi.org\/10.1161\/cir.0000000000001123.","DOI":"10.1161\/CIR.0000000000001137"},{"issue":"1","key":"10.1016\/j.thromres.2024.04.032_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/a-2127-0690","article-title":"The report of community-based and government-endorsed screening program of atrial fibrillation in Taiwan","volume":"124","author":"Chao","year":"2024","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.032_bb0020","doi-asserted-by":"crossref","unstructured":"de Bruijn RF, Heeringa J, Wolters FJ, et al. Association between atrial fibrillation and dementia in the general population. JAMA Neurol. Nov 2015;72(11):1288\u201394. doi:https:\/\/doi.org\/10.1001\/jamaneurol.2015.2161.","DOI":"10.1001\/jamaneurol.2015.2161"},{"key":"10.1016\/j.thromres.2024.04.032_bb0025","doi-asserted-by":"crossref","unstructured":"Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. Cmaj. Apr 3 2012;184(6):E329\u201336. doi:https:\/\/doi.org\/10.1503\/cmaj.111173.","DOI":"10.1503\/cmaj.111173"},{"key":"10.1016\/j.thromres.2024.04.032_bb0030","doi-asserted-by":"crossref","unstructured":"Kalantarian S, Stern TA, Mansour M, Ruskin JN. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med. Mar 5 2013;158(5 Pt 1):338\u201346. doi:https:\/\/doi.org\/10.7326\/0003-4819-158-5-201303050-00007.","DOI":"10.7326\/0003-4819-158-5-201303050-00007"},{"key":"10.1016\/j.thromres.2024.04.032_bb0035","doi-asserted-by":"crossref","unstructured":"Kwok CS, Loke YK, Hale R, Potter JF, Myint PK. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. Mar 8 2011;76(10):914\u201322. doi:https:\/\/doi.org\/10.1212\/WNL.0b013e31820f2e38.","DOI":"10.1212\/WNL.0b013e31820f2e38"},{"issue":"9","key":"10.1016\/j.thromres.2024.04.032_bb0040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/M14-0538","article-title":"Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis","volume":"161","author":"Kalantarian","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"21","key":"10.1016\/j.thromres.2024.04.032_bb0045","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2013.05.074","article-title":"Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function","volume":"62","author":"Gaita","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2024.04.032_bb0050","doi-asserted-by":"crossref","unstructured":"Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. Mar 27 2003;348(13):1215\u201322. doi:https:\/\/doi.org\/10.1056\/NEJMoa022066.","DOI":"10.1056\/NEJMoa022066"},{"issue":"2","key":"10.1016\/j.thromres.2024.04.032_bb0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.thromres.2012.02.006","article-title":"Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry","volume":"130","author":"Nu\u00f1ez","year":"2012","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.04.032_bb0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2024.04.032_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.032_bb0070","doi-asserted-by":"crossref","unstructured":"Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ. New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol. Dec 2013;70(12):1486\u201390. doi:https:\/\/doi.org\/10.1001\/jamaneurol.2013.4021.","DOI":"10.1001\/jamaneurol.2013.4021"},{"issue":"12","key":"10.1016\/j.thromres.2024.04.032_bb0075","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.thromres.2024.04.032_bb0080","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2024.04.032_bb0085","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2024.04.032_bb0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2024.04.032_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.thromres.2024.04.032_bb0100","doi-asserted-by":"crossref","unstructured":"Burdett P, Lip GYH. Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes. Mar 2 2022;8(2):187\u2013194. doi:https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa093.","DOI":"10.1093\/ehjqcco\/qcaa093"},{"key":"10.1016\/j.thromres.2024.04.032_bb0105","article-title":"Optimal stroke preventive strategy for patients aged 80 years or older with atrial fibrillation: a systematic review with traditional and network meta-analysis","volume":"51(12)doi:10.1093\/ageing\/afac292","author":"Lee","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.thromres.2024.04.032_bb0110","doi-asserted-by":"crossref","unstructured":"Gorog DA, Gue YX, Chao TF, et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper. Thromb. Haemost. Oct 2022;122(10):1625\u20131652. doi:https:\/\/doi.org\/10.1055\/s-0042-1750385.","DOI":"10.1055\/s-0042-1750385"},{"key":"10.1016\/j.thromres.2024.04.032_bb0115","doi-asserted-by":"crossref","unstructured":"Romiti GF, Proietti M, Bonini N, et al. Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase II and III. Thromb. Haemost. Dec 2022;122(12):2030\u20132041. doi:https:\/\/doi.org\/10.1055\/s-0042-1756355.","DOI":"10.1055\/s-0042-1756355"},{"issue":"2","key":"10.1016\/j.thromres.2024.04.032_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0043-1769735","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist Oral anticoagulants in patients with atrial fibrillation","volume":"124","author":"Grymonprez","year":"2024","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.032_bb0125","article-title":"Effect of Oral anticoagulants in atrial fibrillation patients with polypharmacy: a Meta-analysis","author":"Zheng","year":"2023","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.032_bb0130","doi-asserted-by":"crossref","unstructured":"Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat. Rev. Cardiol. Nov 2017;14(11):627\u2013628. doi:https:\/\/doi.org\/10.1038\/nrcardio.2017.153.","DOI":"10.1038\/nrcardio.2017.153"},{"issue":"3","key":"10.1016\/j.thromres.2024.04.032_bb0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018Atrial fibrillation better Care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and Meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.04.032_bb0140","doi-asserted-by":"crossref","unstructured":"Romiti GF, Guo Y, Corica B, Proietti M, Zhang H, Lip GYH. Mobile health-technology-integrated Care for Atrial Fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial. Thromb. Haemost. Nov 2023;123(11):1042\u20131048. doi:https:\/\/doi.org\/10.1055\/s-0043-1769612.","DOI":"10.1055\/s-0043-1769612"},{"key":"10.1016\/j.thromres.2024.04.032_bb0145","doi-asserted-by":"crossref","unstructured":"Yu HT, Yang PS, Jang E, et al. Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation. J Am Heart Assoc. Jun 16 2020;9(12):e014177. doi:https:\/\/doi.org\/10.1161\/jaha.119.014177.","DOI":"10.1161\/JAHA.119.014177"},{"key":"10.1016\/j.thromres.2024.04.032_bb0150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnagi.2018.00258","article-title":"Non-vitamin K antagonist Oral anticoagulants and cognitive impairment in atrial fibrillation: insights from the Meta-analysis of over 90,000 patients of randomized controlled trials and real-world studies","volume":"10","author":"Zhang","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.thromres.2024.04.032_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.10.025","article-title":"Oral anticoagulants and risk of dementia: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"96","author":"Mongkhon","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.thromres.2024.04.032_bb0160","article-title":"Risk of incident atrial fibrillation and subsequent use of Oral anticoagulants in patients with dementia","author":"Tsai","year":"2023","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2024.04.032_bb0165","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/joa3.12781","article-title":"Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial)","volume":"38","author":"Bunch","year":"2022","journal-title":"J Arrhythm."},{"key":"10.1016\/j.thromres.2024.04.032_bb0170","article-title":"Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial","volume":"20(1):374","author":"Caramelli","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.thromres.2024.04.032_bb0175","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. Mar 29 2021;372:n71. doi:https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"10.1016\/j.thromres.2024.04.032_bb0180","doi-asserted-by":"crossref","unstructured":"Stare J, Boulch D. Odds Ratio, Hazard Ratio and Relative Risk. Advances in Methodology and Statistics. 01\/01 2016;13:59\u201367. doi:10.51936\/uwah2960.","DOI":"10.51936\/uwah2960"},{"key":"10.1016\/j.thromres.2024.04.032_bb0185","unstructured":"Thorlund K EJ, Wetterslev J, Brok J, Imberger G, Gluud C user manual for trial sequential analysis (TSA) 2nd ed. Copenhagen Trial Unit; 2017:1\u2013119."},{"key":"10.1016\/j.thromres.2024.04.032_bb0190","doi-asserted-by":"crossref","unstructured":"Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. Bmj. Jun 19 2004;328(7454):1490. doi:https:\/\/doi.org\/10.1136\/bmj.328.7454.1490.","DOI":"10.1136\/bmj.328.7454.1490"},{"issue":"2","key":"10.1016\/j.thromres.2024.04.032_bb0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.17085\/apm.21038","article-title":"Trial sequential analysis: novel approach for meta-analysis","volume":"16","author":"Kang","year":"2021","journal-title":"Anesth Pain Med (Seoul)."},{"issue":"18","key":"10.1016\/j.thromres.2024.04.032_bb0200","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2024.04.032_bb0205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/STROKEAHA.113.004009","article-title":"Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham atrial fibrillation treatment of the aged study)","volume":"45","author":"Mavaddat","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2024.04.032_bb0210","doi-asserted-by":"crossref","unstructured":"Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. Mar 3 2011;364(9):806\u201317. doi:https:\/\/doi.org\/10.1056\/NEJMoa1007432.","DOI":"10.1056\/NEJMoa1007432"},{"key":"10.1016\/j.thromres.2024.04.032_bb0215","doi-asserted-by":"crossref","unstructured":"Sagris D, Ntaios G, Buckley BJR, et al. Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation. Eur. J. Intern. Med. 2023\/10\/31\/ 2023;doi: https:\/\/doi.org\/10.1016\/j.ejim.2023.10.033.","DOI":"10.1016\/j.ejim.2023.10.033"},{"key":"10.1016\/j.thromres.2024.04.032_bb0220","doi-asserted-by":"crossref","unstructured":"Rahman AA, Michaud J, Dell'Aniello S, et al. Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study. Neurology. Mar 21 2023;100(12):e1309-e1320. doi:https:\/\/doi.org\/10.1212\/wnl.0000000000206748.","DOI":"10.1212\/WNL.0000000000206748"},{"key":"10.1016\/j.thromres.2024.04.032_bb0225","doi-asserted-by":"crossref","unstructured":"Grymonprez M, Petrovic M, De Backer TL, Ikram MA, Steurbaut S, Lahousse L. Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study. Age Ageing. Mar 1 2023;52(3)doi:https:\/\/doi.org\/10.1093\/ageing\/afad038.","DOI":"10.1093\/ageing\/afad038"},{"issue":"1156","key":"10.1016\/j.thromres.2024.04.032_bb0230","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/postgradmedj-2020-137916","article-title":"Antithrombotic therapy and the risk of new-onset dementia in elderly patients with atrial fibrillation","volume":"98","author":"Wong","year":"2022","journal-title":"Postgrad. Med. J."},{"issue":"3","key":"10.1016\/j.thromres.2024.04.032_bb0235","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40801-022-00311-9","article-title":"Impact of medication adherence on the association between Oral anticoagulant use and risk of dementia: a retrospective cohort study using the Japanese claims database","volume":"9","author":"Komatsu","year":"2022","journal-title":"Drugs Real World Outcomes."},{"issue":"8","key":"10.1016\/j.thromres.2024.04.032_bb0240","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/jgs.17884","article-title":"Oral anticoagulants and outcomes in adults \u226580 years with atrial fibrillation: a global federated health network analysis","volume":"70","author":"Harrison","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.thromres.2024.04.032_bb0245","doi-asserted-by":"crossref","unstructured":"Bezabhe WM, Bereznicki LR, Radford J, et al. Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study. J Am Heart Assoc. Apr 5 2022;11(7):e023098. doi:https:\/\/doi.org\/10.1161\/jaha.121.023098.","DOI":"10.1161\/JAHA.121.023098"},{"issue":"23","key":"10.1016\/j.thromres.2024.04.032_bb0250","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/heartjnl-2021-319672","article-title":"Anticoagulant prescribing for atrial fibrillation and risk of incident dementia","volume":"107","author":"Sharon Louise","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2024.04.032_bb0255","doi-asserted-by":"crossref","unstructured":"Lee SR, Choi EK, Park SH, et al. Comparing warfarin and 4 direct Oral anticoagulants for the risk of dementia in patients with atrial fibrillation. Stroke. Nov 2021;52(11):3459\u20133468. doi:https:\/\/doi.org\/10.1161\/strokeaha.120.033338.","DOI":"10.1161\/STROKEAHA.120.033338"},{"issue":"13","key":"10.1016\/j.thromres.2024.04.032_bb0260","first-page":"4499","article-title":"Selecting the right anticoagulant for stroke prevention in atrial fibrillation","volume":"25","author":"Kundnani","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.thromres.2024.04.032_bb0265","doi-asserted-by":"crossref","unstructured":"Kim D, Yang PS, Jang E, et al. Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation. Europace. Feb 5 2021;23(2):184\u2013195. doi:https:\/\/doi.org\/10.1093\/europace\/euaa192.","DOI":"10.1093\/europace\/euaa192"},{"issue":"5","key":"10.1016\/j.thromres.2024.04.032_bb0270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016437","article-title":"Lower risk of dementia in patients with atrial fibrillation taking non-vitamin K antagonist Oral anticoagulants: a Nationwide population-based cohort study","volume":"10","author":"Hsu","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2024.04.032_bb0275","article-title":"Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: a population-based cohort study","volume":"17(5 Pt A):706-713","author":"Mongkhon","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.thromres.2024.04.032_bb0280","doi-asserted-by":"crossref","unstructured":"S\u00f8gaard M, Skj\u00f8th F, Jensen M, et al. Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study. J Am Heart Assoc. Jun 4 2019;8(11):e011358. doi:https:\/\/doi.org\/10.1161\/jaha.118.011358.","DOI":"10.1161\/JAHA.118.011358"},{"issue":"5","key":"10.1016\/j.thromres.2024.04.032_bb0285","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/joa3.12226","article-title":"One-year clinical outcomes of anticoagulation therapy among Japanese patients with atrial fibrillation: the Hyogo AF network (HAF-NET) registry","volume":"35","author":"Hyogo","year":"2019","journal-title":"J Arrhythm."},{"issue":"2","key":"10.1016\/j.thromres.2024.04.032_bb0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.mayocp.2017.09.021","article-title":"Efficacy of warfarin anticoagulation and incident dementia in a community-based cohort of atrial fibrillation","volume":"93","author":"Madhavan","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.thromres.2024.04.032_bb0295","doi-asserted-by":"crossref","unstructured":"Friberg L, Rosenqvist M. Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J. Feb 7 2018;39(6):453\u2013460. doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehx579.","DOI":"10.1093\/eurheartj\/ehx579"},{"issue":"19","key":"10.1016\/j.thromres.2024.04.032_bb0300","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1212\/WNL.0000000000006456","article-title":"Atrial fibrillation, antithrombotic treatment, and cognitive aging: a population-based study","volume":"91","author":"Ding","year":"2018","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.thromres.2024.04.032_bb0305","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009561","article-title":"Association of Oral Anticoagulant Type with Risk of dementia among patients with Nonvalvular atrial fibrillation","volume":"7","author":"Chen","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.thromres.2024.04.032_bb0310","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjcard.2016.04.039","article-title":"Long-term population-based cerebral ischemic event and cognitive outcomes of direct Oral anticoagulants compared with warfarin among long-term anticoagulated patients for atrial fibrillation","volume":"118","author":"Jacobs","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.thromres.2024.04.032_bb0315","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.113.002236","article-title":"Long-term effects of secondary prevention on cognitive function in stroke patients","volume":"128","author":"Douiri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.04.032_bb0320","doi-asserted-by":"crossref","unstructured":"Barber M, Tait RC, Scott J, Rumley A, Lowe GD, Stott DJ. Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J. Thromb. Haemost. Nov 2004;2(11):1873\u20138. doi:https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00993.x.","DOI":"10.1111\/j.1538-7836.2004.00993.x"},{"issue":"1","key":"10.1016\/j.thromres.2024.04.032_bb0325","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000788","article-title":"Strengths and weaknesses of \u2018real-world\u2019 studies involving non-vitamin K antagonist oral anticoagulants","volume":"5","author":"Camm","year":"2018","journal-title":"Open Heart."},{"issue":"11","key":"10.1016\/j.thromres.2024.04.032_bb0330","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/STROKEAHA.115.008225","article-title":"Atrial fibrillation and cognition","volume":"46","author":"Poggesi","year":"2015","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.thromres.2024.04.032_bb0335","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/europace\/euy046","article-title":"European heart rhythm association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?","volume":"20","author":"Dagres","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.thromres.2024.04.032_bb0340","doi-asserted-by":"crossref","unstructured":"Madhavan M, Graff-Radford J, Piccini JP, Gersh BJ. Cognitive dysfunction in atrial fibrillation. Nat. Rev. Cardiol. Dec 2018;15(12):744\u2013756. doi:https:\/\/doi.org\/10.1038\/s41569-018-0075-z.","DOI":"10.1038\/s41569-018-0075-z"},{"key":"10.1016\/j.thromres.2024.04.032_bb0345","doi-asserted-by":"crossref","unstructured":"Yang PS, Sung JH, Jang E, et al. The Effect of Integrated Care Management on Dementia in Atrial Fibrillation. J Clin Med. Jun 2 2020;9(6)doi:https:\/\/doi.org\/10.3390\/jcm9061696.","DOI":"10.3390\/jcm9061696"},{"issue":"8","key":"10.1016\/j.thromres.2024.04.032_bb0350","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/clc.24076","article-title":"A comparison of the effects of NOAC and VKA therapy on the incidence of dementia in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"46","author":"Wang","year":"2023","journal-title":"Clin. Cardiol."},{"issue":"8","key":"10.1016\/j.thromres.2024.04.032_bb0355","first-page":"1069","article-title":"Blinded randomized trial of anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation (BRAIN-AF): methods and design","volume":"35","author":"Rivard","year":"2019","journal-title":"Can. J. Cardiol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482400152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482400152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:26:30Z","timestamp":1777472790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482400152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":71,"alternative-id":["S004938482400152X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.032","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}